2014-01-07 15:35:56 UTC

Gastroesophageal Reflux Does Not Alter Effects of BMI on Risk of EAC

Jan. 9, 2014

Jesper Lagergren and colleagues report in Clinical Gastroenterology and Hepatology that, based on a population-based study, the association between body mass index (BMI) and esophageal adenocarcinoma (EAC) does not appear to be affected by symptomatic gastroesophageal reflux, although there appears to be synergy between BMI and reflux.

A history of high body mass index (BMI) is associated strongly with a risk of esophageal adenocarcinoma (EAC). Jesper Lagergren and colleagues investigated whether gastroesophageal reflux is involved in this association. They report in Clinical Gastroenterology and Hepatology that, based on a population-based study, the association between BMI and EAC does not appear to be affected by symptomatic gastroesophageal reflux, although there appears to be synergy between BMI and reflux.

Clinical Gastroenterology and Hepatology 2014: 12(1): 45-51

More on Esophageal Cancer

Choose from 30 breakout sessions at the 2018 AGA Postgraduate Course

March 21, 2018

Delve deeper into specific clinical topics that interest you and get concrete action items that can be immediately implemented into your practice.

Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer

March 1, 2018

The researchers found aspirin use was not associated with survival in patients with gastric or esophageal cancer.

Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis

March 1, 2018

In a Markov model, we showed that endoscopic therapy of T1a EAC yields more QALYs and is more cost effective than esophagectomy for patients of all ages and comorbidity indices tested.